Laser-Assisted Regenerative Surgical Therapy for Peri-implantitis

University of Michigan24 enrolled

Overview

The purpose of the study is to evaluate if using Erbium-doped yttrium aluminium garnet laser, Erbium YAG laser (Er:YAG) laser could have adjunctive benefits to the conventional standard mechanical debridement to ablate the infected tissue around the dental implant and detoxify the contaminated implant surface for resolving peri-implant infection and enhance bone regeneration of peri-implant defects.

The purpose of the study is to evaluate if using Er:YAG laser could have adjunctive benefits to the conventional standard mechanical debridement to ablate the infected tissue around the dental implant and detoxify the contaminated implant surface for resolving peri-implant infection and enhance bone regeneration of peri-implant defects. This study involves one center and a double-blinded randomized controlled clinical trial is planned. Twenty-four adult patients in the need of surgical treatment due to peri-implantitis will be included. Six visits are needed for each patient including a 24 week follow-up visit. Specific Aim 1: To compare the clinical benefit of Er:YAG laser-assisted peri-implant defect debridement and surface detoxification with conventional mechanical debridement for regenerative therapy Specific Aim 2: To evaluate whether Er:YAG laser-assisted regenerative surgical therapy can decrease bacterial load and alter microbial profile Specific Aim 3: To analyze whether Er:YAG laser-assisted regenerative surgical therapy can impact the molecular profile of the peri-implant crevicular fluid (PICF) and the stability of the treatment

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Peri-Implantitis

Interventions

Standard mechanical debridementOTHER

Implantoplasty will be performed for peri-implant suprabony defect and infrabony defect will be debrided with dental scalers prior to bone grafting regenerative therapy

Er:YAG laser-assisted debridementDEVICE

Implantoplasty will be performed for peri-implant suprabony defect and infrabony defect will be debrided with the aid of the laser prior to bone grafting regenerative therapy

Eligibility

Sex: ALLMin age: 18 YearsMax age: 85 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Subjects, aged 18 - 85 years * Physical status according to the American Society of Anesthesiologists (ASA) I or II, which includes patients who are systemically healthy or suffer under mild to moderate, but well controlled systemic diseases. * Subjects having a minimum of 1 dental implant with peri-implantitis. * Dental implants with peri-implantitis ≥ 2 threads exposed (infrabony defect) identified on the radiograph and pocket probing depth (PPD) ≥ 5mm, with bleeding on probing (BOP) and/or suppuration (pus) * The implants are in function for at least 6 months * Only rough surface implant will be included in this study Exclusion Criteria: * Long-term use of antibiotics \> 2 weeks in the past two months * Obvious malpositioning of the dental implants * Subjects taking medications known to modify bone metabolism (such as bisphosphonates, corticosteroids, Hormone replacement therapy for menopausal women, parathyroid hormone, Denosumab, strontium ranelate) * Pregnant females or those planning to become pregnant * Subjects with a history of major diseases, oral cancer, sepsis or those having adverse outcomes to oral procedures in the past, will be excluded * Mobility of dental implants * History of alcoholism or drug abuse * Current smokers * Diseases of the immune system or any medical condition that may influence the outcome (uncontrolled diabetes (HbA1c \>8) * Uncontrolled systemic disease or condition known to alter bone metabolism, like Osteoporosis, Osteopenia, Hyperparathyroidism, Paget's disease Premature Exclusion Criteria: * The researcher believes that it is not the best interest of the subject to stay in the study * If the subject becomes ineligible to participate based on the exclusion criteria * If the subject's medical condition requires interventions which preclude involvement in the study (radiation therapy, chemotherapy, etc) * If the subject does not follow study related instructions * The study is suspended or canceled.

Locations (1)

University of Michigan School of Dentistry

Ann Arbor, Michigan, United States

Outcomes

Primary Outcomes

Change in Periodontal Probing Depths (PD)

PD will be measured in millimeters. Change in PD measurements were calculated between baseline and 24 weeks.

Time frame: Baseline and 24 Week

Change in Clinical Attachment Level (CAL)

CAL will be measured in millimeters. Change in subject CAL measurements were calculated between baseline and 24 weeks.

Time frame: Baseline and 24 Week

Change in Bleeding on Probing (BOP)

BOP will be measured dichotomously as 0 or 1. Score 0=no bleeding present Score 1=bleeding present Change in subject BOP score was calculated between baseline and 24 weeks and reported as percent of sites with BOP.

Time frame: Baseline and 24 Week

Change in Radiographic Bone Fill (RBF)

Peri-implant bony defect change will be measured compared to baseline. Participants' standardized radiographs were used to determine bone level changes between baseline and 24 weeks.

Time frame: Baseline and 24 Week

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.